Effect of 6% hydroxyethyl starch 130/0.4 on kidney and haemostatic function in cardiac surgical patients: a randomised controlled trial.


Journal

Anaesthesia
ISSN: 1365-2044
Titre abrégé: Anaesthesia
Pays: England
ID NLM: 0370524

Informations de publication

Date de publication:
09 2020
Historique:
accepted: 30 12 2019
pubmed: 20 2 2020
medline: 2 9 2020
entrez: 20 2 2020
Statut: ppublish

Résumé

Whether third-generation hydroxyethyl starch solutions provoke kidney injury or haemostatic abnormalities in patients having cardiac surgery remains unclear. We tested the hypotheses that intra-operative administration of a third-generation starch does not worsen postoperative kidney function or haemostasis in cardiac surgical patients compared with human albumin 5%. This triple-blind, non-inferiority, clinical trial randomly allocated patients aged 40-85 who underwent elective aortic valve replacement, with or without coronary artery bypass grafting, to plasma volume replacement with 6% starch 130/0.4 vs. 5% human albumin. Our primary outcome was postoperative urinary neutrophil gelatinase-associated lipocalin concentrations, a sensitive and early marker of postoperative kidney injury. Secondarily, we evaluated urinary interleukin-18; acute kidney injury using creatinine RIFLE criteria, coagulation measures, platelet count and function. Non-inferiority (delta 15%) was assessed with correction for multiple comparisons. We enrolled 141 patients (69 starch, 72 albumin) as planned. Results of the primary analysis demonstrated that postoperative urine neutrophil gelatinase-associated lipocalin (median (IQR [range])) was slightly lower with hydroxyethyl starch (5 (1-68 [0-996]) ng.ml

Identifiants

pubmed: 32072617
doi: 10.1111/anae.14994
pmc: PMC9291605
doi:

Substances chimiques

Hemostatics 0
Hydroxyethyl Starch Derivatives 0
Plasma Substitutes 0

Banques de données

ClinicalTrials.gov
['NCT02192502']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1180-1190

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 The Authors. Anaesthesia published by John Wiley & Sons Ltd on behalf of Association of Anaesthetists.

Références

Ren Fail. 2008;30(9):904-13
pubmed: 18925531
Medicine (Baltimore). 2017 May;96(18):e6801
pubmed: 28471979
Kidney Int. 2006 Jul;70(1):199-203
pubmed: 16710348
Medicine (Baltimore). 2019 Feb;98(7):e14383
pubmed: 30762739
Br J Anaesth. 2014 Jan;112(1):25-34
pubmed: 24046292
Crit Care. 2015 Mar 17;19:87
pubmed: 25886765
Intensive Care Med. 2004 Jan;30(1):33-7
pubmed: 14618231
N Engl J Med. 2012 Nov 15;367(20):1901-11
pubmed: 23075127
Br J Anaesth. 2016 Oct;117(4):458-463
pubmed: 28077532
Perfusion. 2018 Sep;33(6):483-489
pubmed: 29199540
Anesthesiology. 2018 Jan;128(1):55-66
pubmed: 29068831
Anesthesiology. 2013 Feb;118(2):387-94
pubmed: 23340352
Anesth Analg. 2013 Jan;116(1):35-48
pubmed: 23115254
J Am Soc Nephrol. 2012 May;23(5):905-14
pubmed: 22383693
Iran J Pharm Res. 2012 Summer;11(3):705-14
pubmed: 24250497
J Cardiothorac Vasc Anesth. 2016 Aug;30(4):869-75
pubmed: 26774199
J Thorac Cardiovasc Surg. 2012 Jul;144(1):223-30
pubmed: 22578894
Eur J Anaesthesiol. 2016 Jan;33(1):42-8
pubmed: 26351826
Anesthesiology. 2019 May;130(5):728-744
pubmed: 30882476
Br J Anaesth. 2016 Oct;117(4):442-449
pubmed: 28077530
Eur J Clin Pharmacol. 2011 Aug;67(8):767-82
pubmed: 21365330
Clin J Am Soc Nephrol. 2008 May;3(3):665-73
pubmed: 18337554
Anesth Analg. 2008 Aug;107(2):382-90
pubmed: 18633012
J Cardiothorac Vasc Anesth. 2018 Feb;32(1):205-211
pubmed: 29221978
Crit Care. 2014 Dec 04;18(6):656
pubmed: 25475406
J Cardiothorac Vasc Anesth. 2017 Oct;31(5):1639-1648
pubmed: 28372955
Semin Thromb Hemost. 1995;21 Suppl 4:7-13
pubmed: 8747682
Am J Kidney Dis. 2013 Dec;62(6):1058-67
pubmed: 23830182
Crit Care. 2004 Aug;8(4):R204-12
pubmed: 15312219
N Engl J Med. 2012 Jul 12;367(2):124-34
pubmed: 22738085
Anaesthesia. 2018 Feb;73(2):205-215
pubmed: 29150842
Asian Cardiovasc Thorac Ann. 2009 Aug;17(4):368-72
pubmed: 19713332
Anesthesiology. 2019 Feb;130(2):227-236
pubmed: 30418217
Crit Care Med. 2013 Nov;41(11):2532-42
pubmed: 23978813
PLoS One. 2017 Oct 18;12(10):e0186403
pubmed: 29045467
Crit Care Med. 2009 Feb;37(2):696-701
pubmed: 19114887
J Thorac Cardiovasc Surg. 2016 Jun;151(6):1476-81
pubmed: 26952930
Nephrol Dial Transplant. 2008 Feb;23(2):566-72
pubmed: 17911094

Auteurs

A E Duncan (AE)

Departments of Cardiothoracic Anesthesiology and Outcomes Research, Cleveland Clinic, Cleveland, OH, USA.

Y Jia (Y)

Department of Outcomes Research, Cleveland Clinic, Cleveland, OH, USA.

E Soltesz (E)

Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH, USA.

S Leung (S)

Department of Outcomes Research, Cleveland Clinic, Cleveland, OH, USA.

H O Yilmaz (HO)

Department of Outcomes Research, Cleveland Clinic, Cleveland, OH, USA.

G Mao (G)

Departments of Quantitative Health Sciences and Outcomes Research, Cleveland Clinic, Cleveland, OH, USA.

A A Timur (AA)

Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA.

K Kottke-Marchant (K)

Department of Pathology and Laboratory Administration, Cleveland Clinic, Cleveland, OH, USA.

H J Rogers (HJ)

Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA.

C Ma (C)

Departments of Quantitative Health Sciences and Outcomes Research, Cleveland Clinic, Cleveland, OH, USA.

I Ince (I)

Department of Outcomes Research, Cleveland Clinic, Cleveland, OH, USA.

N Karimi (N)

Department of Outcomes Research, Cleveland Clinic, Cleveland, OH, USA.

S Yagar (S)

Department of Outcomes Research, Cleveland Clinic, Cleveland, OH, USA.

C Trombetta (C)

Department of Cardiothoracic Anesthesiology, Cleveland Clinic, Cleveland, OH, USA.

D I Sessler (DI)

Department of Outcomes Research, Cleveland Clinic, Cleveland, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH